Sports and Exercise Medicine Clinic, Asklipiou 17, 54639 Thessaloniki, Greece; National Track and Field Centre, Sports Medicine Clinic of S.E.G.A.S., Thessaloniki, Greece; European Sports Care, 68 Harley Street, London W1G 7HE, UK; Centre for Sports & Exercise Medicine, Queen Mary University of London, Bancroft Road, London E1 4DG, UK.
King's College London Medical School, London SE1 1UL, UK.
Biomed Res Int. 2016;2016:9415827. doi: 10.1155/2016/9415827. Epub 2016 Jul 5.
Background and Aims. The exploration of an individualised protocol of radial extracorporeal shock wave therapy (rESWT) for plantar fasciopathy, assessing success rates and the recurrence rate over a 1-year period after treatment, is not yet identified in literature. Methods and Results. Between 2006 and 2013, 68 patients (78 heels) were assessed for plantar fasciopathy. An individualised rESWT treatment protocol was applied and retrospectively analysed. Heels were analysed for mean number of shock wave impulses, mean pressure, and mean frequency applied. Significant mean pain reductions were assessed through Visual Analogue Scale (VAS) after 1-month, 3-month, and 1-year follow-up. Success rates were estimated as the percentage of patients having more than 60% VAS pain decrease at each follow-up. 1-year recurrence rate was estimated. The mean VAS score before treatment at 6.9 reduced to 3.6, 1 month after the last session, and to 2.2 and 0.9, after 3 months and 1 year, respectively. Success rates were estimated at 19% (1 month), 70% (3 months), and 98% (1 year). The 1-year recurrence rate was 8%. Moderate positive Spearman's rho correlation (r = 0.462, p < 0.001) was found between pretreatment pain duration and the total number of rESWT sessions applied. Conclusions. Individualised rESWT protocol constitutes a suitable treatment for patients undergoing rESWT for plantar fasciitis.
背景与目的。目前,文献中尚未探讨针对足底筋膜炎的个体化径向体外冲击波疗法(rESWT)方案,评估治疗后 1 年的成功率和复发率。
方法和结果。2006 年至 2013 年间,对 68 例(78 足跟)足底筋膜炎患者进行了评估。应用个体化 rESWT 治疗方案进行回顾性分析。分析足跟的平均冲击波脉冲数、平均压力和平均频率。通过视觉模拟评分(VAS)在 1 个月、3 个月和 1 年随访时评估疼痛的显著平均降低。成功率估计为每个随访时 VAS 疼痛减轻超过 60%的患者百分比。估计 1 年的复发率。治疗前的平均 VAS 评分为 6.9,在最后一次治疗结束后 1 个月降至 3.6,3 个月后降至 2.2,1 年后降至 0.9。1 个月的成功率为 19%,3 个月的成功率为 70%,1 年的成功率为 98%。1 年的复发率为 8%。治疗前疼痛持续时间与 rESWT 治疗次数之间存在中度正相关(r=0.462,p<0.001)。
结论。个体化 rESWT 方案是治疗足底筋膜炎患者的一种合适选择。